To identify the cancer types in which increased expression of COL4A1 was correlated with patient survival, we performed a Kaplan–Meier survival analysis of two patient groups split by optimal cut-off to maximize survival differences in TCGA datasets depending on the expression levels of COL4A1. This evidence concerns the gene COL4A1 and cancer.